Dr Rebecca Tadokera's Writing Portfolio

As a medical writer and scientific consultant, I leverage my passion for science, deep understanding of scientific and medical research, experience, and creativity to create compelling and audience-targeted content that adds value to my clients in the life sciences business.

After more than 12 years of working in academic research, I swapped my pipettes and lab coat for a keypad and laptop. I have passion and a real commitment to see science make an impact in society. Scientific communication, coupled with training other young scientists to make a similar transition is my avenue for realising this passion.

My specialisation is in the immunology, oncology, and infectious diseases therapeutic areas.

Contact me via email at tadokerar@gmail.com for quotes and availability.

Medical Writing vs. Academic Writing: What’s the Difference? – ScieHealth Scientific and Medical Communications

Medical writing and academic writing are two distinct forms of professional writing used for different purposes and audiences. While both are used to communicate information, there are some key differences between the two that set them apart. Understanding these differences is important for writers who work in the fields of medicine and academia, as well as for anyone who needs to distinguish between the two or is considering a career change.

Medical writing is used to communicate information a

From Academia to Medcomms: My Reflections and Learnings – ScieHealth Scientific and Medical Communications

From Academia to Medcomms: My Reflections and Learnings

It’s been over a year since I transitioned from academia to medical writing, in a medical writing or medcomms agency. In this article, I will reflect on and share ten learnings from working in a medcomms agency environment and compare and contrast these with my academic experience. I hope that these learnings will bring some perspective to academics considering a similar career change.

Learning #1: The real meaning of teamwork in medcomms

Banking on Future Health

By collecting long-term population health data, the Tohoku Medical Megabank Project paves the way for precision medicine and better health in Japan’s earthquake-stricken areas.

Located at the intersection of four continental and oceanic plates, Japan is more prone to nearly 1,500 earthquakes every year. In March 2011, Japan experienced its strongest earthquake in recorded history: the Great East Japan Earthquake that struck the Tohoku region.

Building a Basis for Precision Medicine in Japan

Through his work at Japan’s Tohoku University Tohoku M edical Mega bank Organization, Professor Masayuki Yamamoto is bringing precision medicine to where the country needs it most.

Every living creature on earth carries in their DNA the instructions to make each one unique. Yet despite the diversity we see, all human beings are remarkably similar at the genetic level— up to 99.9 percent according to the Human Genome Project1.
The Nuts  and Bolts of a Needs Assessment

Increasing Participation Rates of Black Cancer Patients in Clinical Trials

The low participation rates of Black patients in clinical trials remains a significant concern for cancer clinical trial management, sponsors, and drug manufacturers. Clinical trials are the foundation on which new treatments emerge. Clinical trial participation rates must therefore be representative of the demographic distribution of the target population.